Skip to content

4 vs 7 Points Blood Glucose Monitoring in Gestational Diabetes on Dietary Modification

4 Versus 7 Points Self-monitoring Blood Glucose in Gestational Diabetes on Diet Modification-A Randomised Control Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04101396
Enrollment
200
Registered
2019-09-24
Start date
2019-10-25
Completion date
2022-06-30
Last updated
2023-11-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gestational Diabetes Mellitus in Pregnancy

Keywords

diet modification, 4 and 7 points monitoring

Brief summary

This study aims to compare between 4 and 7 points blood glucose monitoring in women with gestational diabetes on diet modification.

Detailed description

All women with gestational diabetes on diet modification will be recruited and randomised to 4 versus 7 points self monitoring blood glucose. They will be followed up 4 weekly and the pregnancy outcomes will be evaluated.

Interventions

DIETARY_SUPPLEMENTdiabetic diet

Patients with gestational diabetes will be seen by the dietitian to be taught diet modification

Sponsors

National University of Malaysia
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
NONE

Intervention model description

All women with gestational diabetes are randomised to 4 or 7 points of self monitoring blood glucose.

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 45 Years
Healthy volunteers
No

Inclusion criteria

* Aged 18-45 years old * Pregnant women with gestational diabetes mellitus on diet modification * Confirmed gestational diabetes mellitus using National Institute for Health and Care Excellence guideline by 75g oral glucose tolerance test after 14 weeks * Gestational age at recruitment 20-34 week

Exclusion criteria

* bad obstetrics history. * Women with underlying medical disorders such as hypertension, autoimmune diseases on steroids * fetal anomaly. * Women planning to deliver in other centres * Women who refuse to participate

Design outcomes

Primary

MeasureTime frameDescription
Pregnancy outcome of participantsFrom date of randomisation up to 40 weeks gestationMean gestational age at delivery in weeks
Demographic data of participantsOn the date of randomisationMean age of participants in years
Clinical characteristics of participantsOn the date of randomisation up to 40 weeks gestationMean gestational age gestational diabetes mellitus is diagnosed in weeks

Secondary

MeasureTime frameDescription
Requirement of treatment in participantsFrom the date of randomisation up to 40 weeks gestationMean gestational age that the participants are detected to require added treatment in weeks
Participants' complianceFrom point of randomisation till 40 weeks gestationRate of frequency of four weekly self blood glucose monitoring in percentage
Participants' satisfactionFrom point of randomisation till 40 weeks gestationRate of participants' satisfaction whether satisfied, neutral or not satisfied in percentage

Countries

Malaysia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 6, 2026